Toripalimab Plus Sorafenib in Patients With Advanced-Stage Hepatocellular Carcinoma (Toripalimab)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04926532

Recruitment Status : Unknown

Verified May 2021 by Shanghai Zhongshan Hospital.
Recruitment status was: Recruiting

First Posted : June 15, 2021

Last Update Posted : June 15, 2021

View this study on the modernized ClinicalTrials.gov

Sponsor:

Information provided by (Responsible Party):

Shanghai Zhongshan Hospital

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	October 31, 2021
Estimated Study Completion Date :	December 31, 2021

To Top